ELVN
NASDAQStockEnliven Therapeutics, Inc.
$29.36-1.34 (-4.36%)
52-Week Range
$14.91
$30.70
Key Stats
Market Cap
1.7B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.06
Volume
540.5K
Avg Volume
742.4K
Performance
1M
+2.86%
3M
+67.79%
6M
+55.73%
YTD
+85.39%
1Y
+41.99%
3Y
+29.19%
5Y
+21.31%
Price Chart
ETF Exposure
ELVN is held by 59 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| XPH | State Street SPDR S&P Pharmaceuticals ETF | 2.21% |
| BBC | Virtus Biotech Clinical Trials ETF | 1.33% |
| FMED | FIDELITY DISRUPTIVE MEDICINE ETF | 0.75% |
| PILL | Direxion Daily Pharmaceutical & Medical Bull 3X ETF | 0.44% |
| IHE | iShares U.S. Pharmaceuticals ETF | 0.35% |
| IWC | iShares Micro-Cap ETF | 0.25% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.14% |
| IBB | iShares Biotechnology ETF | 0.11% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.09% |
| RFLR | Innovator U.S. Small Cap Managed Floor ETF | 0.08% |
| DFAS | Dimensional - US Small Cap ETF | 0.07% |
| AVSC | Avantis U.S. Small Cap Equity ETF | 0.07% |
| VTWG | Vanguard Russell 2000 Growth ETF | 0.07% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.06% |
| ESML | iShares ESG Aware MSCI USA Small-Cap ETF | 0.06% |
| IWM | iShares Russell 2000 ETF | 0.04% |
| ISCV | iShares Morningstar Small-Cap Value ETF | 0.04% |
| JKL | iShares Morningstar Small-Cap Value ETF | 0.04% |
| RSSL | Global X - Russell 2000 ETF | 0.04% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.03% |
| VTWO | Vanguard Russell 2000 ETF | 0.03% |
| UWM | ProShares - Ultra Russell2000 | 0.03% |
| URTY | ProShares - UltraPro Russell2000 | 0.02% |
| ISCB | iShares Morningstar Small-Cap ETF | 0.02% |
| JKJ | iShares Morningstar Small-Cap ETF | 0.02% |
| OMFS | Invesco Russell 2000 Dynamic Multifactor ETF | 0.02% |
| FHLC | FIDELITY MSCI HEALTH CARE INDEX ETF | 0.01% |
| VXF | Vanguard Extended Market ETF | 0.01% |
| VHT | Vanguard Health Care ETF | 0.01% |
| SMMD | iShares Russell 2500 ETF | 0.01% |
| WSML | iShares MSCI World Small-Cap ETF | 0.01% |
| ONEQ | FIDELITY NASDAQ COMPOSITE INDEX ETF | 0.01% |
| HDG | ProShares - Hedge Replication ETF | 0.01% |
| DFUS | Dimensional - US Equity Market ETF | 0.01% |
| DXUV | Dimensional - US Vector Equity ETF | 0.01% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.00% |
| DCOR | Dimensional - US Core Equity 1 ETF | 0.00% |
| DFAC | Dimensional - US Core Equity 2 ETF | 0.00% |
| DFAU | Dimensional - US Core Equity Market ETF | 0.00% |
| EAOA | iShares ESG Aware 80/20 Aggressive Allocation ETF | 0.00% |
| IWV | iShares Russell 3000 ETF | 0.00% |
| SCHB | Schwab U.S. Broad Market ETF | 0.00% |
| VTHR | Vanguard Russell 3000 ETF | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| EAOK | iShares ESG Aware 30/70 Conservative Allocation ETF | 0.00% |
| EAOM | iShares ESG Aware 40/60 Moderate Allocation ETF | 0.00% |
| EAOR | iShares ESG Aware 60/40 Balanced Allocation ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
Page 1 of 2Next
About ELVN ETF Exposure
Enliven Therapeutics, Inc. (ELVN) is held by 59 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.7B, ELVN is a widely held institutional stock. The stock currently trades at $29.36. Investors can gain exposure to ELVN through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ELVN, sorted by portfolio weight.